STEADY-STATE PHARMACOKINETICS OF 2 SUSTAINED-RELEASE THEOPHYLLINE PRODUCTS DURING ONCE-DAILY AND TWICE-DAILY DOSING

被引：0
作者：
ARMSTRONG, EP [1 ]
NAKO, N [1 ]
PLEZIA, PM [1 ]
KRAMER, TH [1 ]
JONES, WN [1 ]
机构：
[1] UNIV ARIZONA,COLL PHARM,TUCSON,AZ 85721
来源：
CLINICAL PHARMACY | 1987年 / 6卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：800 / 804
页数：5
相关论文
共 50 条
  • [21] A ONCE-DAILY VERSUS A TWICE-DAILY THEOPHYLLINE PREPARATION IN THE TREATMENT OF NOCTURNAL ASTHMA
    MARTIN, RJ
    ANNALS OF ALLERGY, 1988, 61 (05): : 402 - 402
  • [22] PHARMACOKINETICS OF ONCE-DAILY VERAPAMIL - COMPARATIVE BIOAVAILABILITY OF 2 SUSTAINED-RELEASE FORMULATIONS
    MUIRHEAD, DC
    NORRIS, RJ
    COCKAYNE, D
    HILL, GWR
    BRITISH JOURNAL OF CLINICAL PRACTICE, 1988, 42 (04): : 14 - 19
  • [23] A clinical and pharmacologic assessment of once-daily versus twice-daily dosing for rivaroxaban
    Reinhold Kreutz
    Journal of Thrombosis and Thrombolysis, 2014, 38 : 137 - 149
  • [24] Once-daily and twice-daily dosing of p-aminosalicylic acid granules
    Peloquin, CA
    Berning, SE
    Huitt, GA
    Childs, JM
    Singleton, MD
    James, GT
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : 932 - 934
  • [25] Steady-state pharmacokinetics of lamotrigine when converting from a twice-daily immediate-release to a once-daily extended-release formulation in subjects with epilepsy (The COMPASS Study)
    Tompson, Debra J.
    Ali, Imran
    Oliver-Willwong, Ruth
    Job, Sarah
    Zhu, Li
    Lemme, Francesca
    Hammer, Anne E.
    Vuong, Alain
    Messenheimer, John A.
    EPILEPSIA, 2008, 49 (03) : 410 - 417
  • [26] Difference in nephrotoxicity of vancomycin administered as once-daily and twice-daily dosing regimens
    Konishi, Hiroki
    Noda, Satoshi
    Sumi, Masaki
    Hoshino, Nobuo
    Minouchi, Tokuzo
    Akiba, Satoshi
    Sato, Takashi
    Yamaji, Akira
    THERAPEUTIC DRUG MONITORING, 2007, 29 (04) : 541 - 541
  • [27] ONCE-DAILY VERSUS TWICE-DAILY DOSING OF DIGOXIN IN THE PEDIATRIC AGE GROUP
    ZALZSTEIN, E
    KOREN, G
    LEVY, M
    BENTUR, Y
    MACLEOD, S
    FREEDOM, R
    JOURNAL OF PEDIATRICS, 1990, 116 (01) : 137 - 139
  • [28] A clinical and pharmacologic assessment of once-daily versus twice-daily dosing for rivaroxaban
    Kreutz, Reinhold
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2014, 38 (02) : 137 - 149
  • [29] STEADY-STATE PHARMACOKINETICS AND EFFECTS OF A NEW ONCE-DAILY, SLOW-RELEASE THEOPHYLLINE CAPSULE PREPARATION IN ASTHMA
    WILLIAMS, PE
    ALWAZIR, YA
    ROUTLEDGE, PA
    CAMPBELL, IA
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 22 (04) : 383 - 387
  • [30] Pharmacokinetics, pharmacodynamics and safety of once-daily versus twice-daily dosing with enfuvirtide in HIV-infected subjects
    Thompson, M
    DeJesus, E
    Richmond, G
    Wheeler, D
    Flaherty, J
    Piliero, P
    True, A
    Chiu, YY
    Zhang, Y
    McFalls, E
    Miralles, GD
    Patel, IH
    AIDS, 2006, 20 (03) : 397 - 404
12345